| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |